Part, Chapter, Paragraph

 1 I, 1,1(8)   |        prevention versus progress. Nature Med. 1996, 2: 18-21; Hammer
 2 I, 2,2(18)  |           organ donors for humans, Nature Medicine 1995, 1: 964-6;
 3 I, 2,2(18)  |    xenografts from tumoral injury, Nature Med 1995, 1: 423-7; Cowan
 4 I, 2,2(19)  |     complement-mediated cytolysis, Nature Medicine 1995, 1: 1261-7. ~
 5 I, 2,3(33)  |    xenografts from tumoral injury, Nature Med 1995, 1: 423-7; Cozzi
 6 I, 2,3(34)  |    xenografts from tumoral injury, Nature Med 1995, 1: 423-7. ~
 7 I, 2,4(41)  |     endogenous retrovirus of pigs. Nature Med 3: 282-286. ~
 8 I, 2,5(43)  |          from adult somatic cells, Nature. 2000, 407: 86-90; Onishi
 9 II, 1,7     |           specifically theological nature of such a question, we deem
10 II, 1,7(50) |           a theological-liturgical nature, used in Gn 1: 1-31; for
11 II, 1,8     | superiority is founded on the very nature of the human person, whose
12 II, 1,8     |           two issues of an ethical nature must be addressed. First,
13 II, 1,10    |    considerations of a theological nature, and perhaps even before
14 II, 2,12(64)|            versus Collective Risk, Nature Medicine, 1998, 4:  141-
15 II, 2,14(68)|            to Xenotransplantation, Nature, 1995, 378: 434; National